(Q44693601)

5 December 2017

title

Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder (English)

1 reference

obsessive-compulsive disorder

5 December 2017

0 references

1 reference

9

1 reference

5 December 2017

3

Gabriele Pöpperl

1 reference

5 December 2017

1

Oliver Pogarell

1 reference

5 December 2017

8

Hans-Jürgen Möller

1 reference

5 December 2017

4

Georg Juckel

1 reference

5 December 2017

6

Michael Zaudig

1 reference

5 December 2017

7

Michael Riedel

1 reference

5 December 2017

Christine Hamann

2

1 reference

5 December 2017

Martina Choukèr

series ordinal

5

1 reference

5 December 2017

Klaus Tatsch

series ordinal

10

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

5 December 2017

published in

Biological Psychiatry

1 reference

5 December 2017

volume

54

1 reference

5 December 2017

issue

12

1 reference

5 December 2017

page(s)

1406-1413

1 reference

An Inventory for Measuring Depression

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder? A review of the pediatric literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

The Yale-Brown Obsessive Compulsive Scale. II. Validity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Reduced central serotonin transporters in alcoholism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Serotonergic Function in Obsessive-Compulsive Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CIT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Toward a neuroanatomy of obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Initial experience with single-photon emission tomography using iodine-123-labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl) tropane in human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

N-substituted analogs of 2 beta-carbomethoxy-3 beta- (4'-iodophenyl)tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

?-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Quantitative electroencephalographic subtyping of obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Adults with early-onset obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Estrogen-serotonin interactions: implications for affective regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

[123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

[123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Pharmacotherapy of obsessive-compulsive disorder: experience with the selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900183-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(03)00183-5

1 reference

5 December 2017

1 reference